The Claim
Oral glutamine supplementation at 30 g/day during radiochemotherapy for advanced esophageal cancer is not associated with reported adverse events in a small trial, but the absence of reported adverse events does not establish safety.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In a small study, people with advanced esophageal cancer who took 30 grams of glutamine daily during radiation and chemotherapy did not report any adverse events, but this does not prove the supplement is safe.
See the scientific wording
Oral glutamine supplementation at 30 g/day during radiochemotherapy for advanced esophageal cancer does not appear to cause harm based on the absence of reported adverse events in a small trial, but this cannot be used to conclude safety.
Glutamine enters the bloodstream and feeds immune cells and gut lining cells, helping them stay alive and work properly under the stress of cancer treatment. It also helps make a molecule that protects cells from damage caused by radiation and chemotherapy, keeping the gut barrier intact and immune cells active.
What the research says
1 studyIn a small group of 13 cancer patients, taking 30 grams of glutamine daily during treatment didn’t cause any noticeable side effects and even helped their bodies cope better. But since only a few people were studied, we can’t say it’s safe for everyone.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.